R&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.
Richard Mark Kirkner
Advertisement
Richard Mark Kirkner is an independent healthcare journalist in the Greater Philadelphia area.
Articles by Richard Mark Kirkner
Advertisement
Latest Updated Articles
- The market side of biosimilars
August 10th 2015
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Explaining COVID-19 Vaccine Side Effects to Anxious Patients
3
Hormone Replacement Therapy May Lower Dementia Risk in Postmenopausal Women
4
Expert Discusses Flu and COVID-19 Vaccine Guidance
5